Fralick, M., Sacks, C. A., & Kesselheim, A. S. (2019). Assessment of Use of Combined Dextromethorphan and Quinidine in Patients With Dementia or Parkinson Disease After US Food and Drug Administration Approval for Pseudobulbar Affect. JAMA Intern Med.
Chicago Style aipamenaFralick, Michael, Chana A. Sacks, and Aaron S. Kesselheim. "Assessment of Use of Combined Dextromethorphan and Quinidine in Patients With Dementia or Parkinson Disease After US Food and Drug Administration Approval for Pseudobulbar Affect." JAMA Intern Med 2019.
MLA aipamenaFralick, Michael, Chana A. Sacks, and Aaron S. Kesselheim. "Assessment of Use of Combined Dextromethorphan and Quinidine in Patients With Dementia or Parkinson Disease After US Food and Drug Administration Approval for Pseudobulbar Affect." JAMA Intern Med 2019.